BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2468670)

  • 1. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.
    Tandon NN; Kralisz U; Jamieson GA
    J Biol Chem; 1989 May; 264(13):7576-83. PubMed ID: 2468670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood.
    Diaz-Ricart M; Tandon NN; Carretero M; Ordinas A; Bastida E; Jamieson GA
    Blood; 1993 Jul; 82(2):491-6. PubMed ID: 7687161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
    Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
    Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet adhesion to collagen in individuals lacking glycoprotein IV.
    McKeown L; Vail M; Williams S; Kramer W; Hansmann K; Gralnick H
    Blood; 1994 May; 83(10):2866-71. PubMed ID: 7514049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesive functions of platelets lacking glycoprotein IV (CD36).
    Tandon NN; Ockenhouse CF; Greco NJ; Jamieson GA
    Blood; 1991 Dec; 78(11):2809-13. PubMed ID: 1720035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
    Kieffer N; Guichard J; Breton-Gorius J
    Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions.
    Diaz-Ricart M; Tandon NN; Gómez-Ortiz G; Carretero M; Escolar G; Ordinas A; Jamieson GA
    Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):883-8. PubMed ID: 8673564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV.
    Saelman EU; Kehrel B; Hese KM; de Groot PG; Sixma JJ; Nieuwenhuis HK
    Blood; 1994 Jun; 83(11):3240-4. PubMed ID: 8193359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
    Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
    J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression.
    Aiken ML; Ginsberg MH; Byers-Ward V; Plow EF
    Blood; 1990 Dec; 76(12):2501-9. PubMed ID: 1702328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets.
    Tandon NN; Holland EA; Kralisz U; Kleinman HK; Robey FA; Jamieson GA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):535-42. PubMed ID: 1826081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of platelet glycoprotein IV (CD36).
    Tandon NN; Lipsky RH; Burgess WH; Jamieson GA
    J Biol Chem; 1989 May; 264(13):7570-5. PubMed ID: 2468669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07.
    Alessio M; Greco NJ; Primo L; Ghigo D; Bosia A; Tandon NN; Ockenhouse CF; Jamieson GA; Malavasi F
    Blood; 1993 Dec; 82(12):3637-47. PubMed ID: 7505121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36).
    Siddiqui FA; Lian EC
    Biochem Int; 1992 Jul; 27(3):485-96. PubMed ID: 1384492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay.
    Thibert V; Bellucci S; Edelman L; Tandon NN; Legrand C
    Thromb Haemost; 1992 Nov; 68(5):600-5. PubMed ID: 1280864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1.
    Jandrot-Perrus M; Lagrue AH; Okuma M; Bon C
    J Biol Chem; 1997 Oct; 272(43):27035-41. PubMed ID: 9341142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation results in a redistribution of glycoprotein IV (CD36).
    Michelson AD; Wencel-Drake JD; Kestin AS; Barnard MR
    Arterioscler Thromb; 1994 Jul; 14(7):1193-201. PubMed ID: 7517184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.
    Lecut C; Feeney LA; Kingsbury G; Hopkins J; Lanza F; Gachet C; Villeval JL; Jandrot-Perrus M
    J Thromb Haemost; 2003 Dec; 1(12):2653-62. PubMed ID: 14675102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation.
    Nakamura T; Jamieson GA; Okuma M; Kambayashi J; Tandon NN
    J Biol Chem; 1998 Feb; 273(8):4338-44. PubMed ID: 9468482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction.
    Beer JH; Rabaglio M; Berchtold P; von Felten A; Clemetson KJ; Tsakiris DA; Kehrel B; Brandenberger S
    Blood; 1993 Aug; 82(3):820-9. PubMed ID: 7687896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.